Medicine and Dentistry
Pediatrics
100%
Diseases
60%
Systematic Review
33%
Childbirth
26%
Childhood Cancer
24%
Quality of Life
24%
Meta-Analysis
23%
Magnetic Resonance Imaging
23%
Symptom
22%
Adolescent
22%
Cohort Analysis
21%
Cystic Fibrosis
20%
Body Mass Index
19%
Biological Marker
19%
Emergency Department
18%
Diagnosis
18%
Asthma
18%
Randomized Controlled Trial
18%
Glycogen Storage Disease Type II
18%
Observational Study
17%
Neonates
17%
Inflammatory Bowel Disease
17%
First Trimester Pregnancy
17%
Pediatrics Patient
16%
Prospective Cohort Study
16%
Infection
15%
Child
15%
Gestational Age
15%
COVID-19
15%
Prevalence
14%
Acute Lymphoblastic Leukemia
13%
Odds Ratio
13%
Malignant Neoplasm
13%
Obesity
13%
Sepsis
12%
Computer Assisted Tomography
12%
Surgery
11%
Prematurity
11%
Neoplasm
10%
Cross Sectional Study
10%
Neonatal Infant
10%
Small for Gestational Age
10%
Premature Labor
10%
Blood Pressure
9%
Health Outcomes
9%
Clinical Trial
9%
Intensive Care
9%
Cardiovascular System
9%
Antibiotics
9%
Persistent Truncus Arteriosus
9%
Rectum Cancer
9%
Hydrocortisone
9%
Drug Therapy
8%
Parenteral Nutrition
8%
Human Immunodeficiency Virus
8%
Pregnancy
8%
Bacterial Infection
8%
Silo-Filler's Disease
8%
Enzyme Replacement Therapy
7%
Adverse Event
7%
Injury
7%
Congenital Diaphragm Hernia
7%
Retrospective Cohort Study
7%
Infancy
7%
Bleeding Disorder
7%
Clinician
7%
Smoke
7%
Fetus Growth
7%
Pharmacokinetics
7%
Acute Myeloid Leukemia
7%
Intensive Care Unit
6%
Bleeding
6%
Growth Hormone
6%
Population
6%
Haemophilia
6%
Logistic Regression Analysis
6%
Child Health
6%
Crohn's Disease
6%
Intestinal Failure
6%
Hodgkin's Lymphoma
6%
Neonatal Intensive Care Unit
6%
Decision Making
6%
Childhood Obesity
6%
Birth Weight
6%
Diabetes
6%
Physical Activity
6%
Prader-Willi Syndrome
6%
Neurofibromatosis Type I
6%
Placebo
6%
Cardiac Magnetic Resonance Imaging
6%
Intima-Media Thickness
6%
Exercise
5%
Triage
5%
Patient-Reported Outcome
5%
Mental Health
5%
Haemophilia A
5%
Cardiovascular Disease
5%
Phthalic Acid
5%
Fatty Liver
5%
Respiratory Tract Infection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
29%
Disease
24%
Asthma
13%
Biological Marker
12%
Infection
11%
Cohort Study
11%
Randomized Controlled Trial
10%
Glycogen Storage Disease Type 2
10%
Symptom
9%
Haemophilia A
9%
Prospective Cohort Study
9%
Acute Lymphoblastic Leukemia
9%
Inflammatory Bowel Disease
8%
Replacement Therapy
8%
Cystic Fibrosis
8%
Prematurity
8%
Antibiotics
8%
Childhood Cancer
8%
Blood Clotting Factor 8
8%
Malignant Neoplasm
8%
Adverse Event
7%
Premature Labor
7%
Observational Study
7%
Crohn's Disease
7%
Sepsis
7%
Prevalence
6%
Inflammation
6%
Placebo
6%
Clinical Trial
6%
Obesity
6%
Bacterial Infection
6%
Bleeding
5%
Phthalic Acid
5%
Growth Hormone
5%
Remission
5%
Haemophilia
5%
Syndrome
5%
Antibiotic Agent
5%
Biochemistry, Genetics and Molecular Biology
Genetics
23%
DNA Methylation
21%
Progeny
18%
Cohort Study
16%
First Trimester Pregnancy
13%
Epigenome
12%
Body Mass
11%
Prospective Cohort Study
9%
Prevalence
8%
Enzyme
7%
Metabolite
7%
Fat Mass
7%
Myeloid
6%
Body Composition
6%
Blood Pressure
6%
Newborn Screening
6%
Genotyping
6%
Gene Expression
6%
B Cell
6%
Population
5%
Genome-Wide Association Study
5%
Epigenetics
5%
Small for Date Infant
5%
Pharmacokinetics
5%
Methylation
5%
Growth Hormone
5%
Bovine Somatotropin
5%
Precursor
5%